Skip to main content
BMRN logo

BMRN · Biomarin Pharmaceutical Inc

Track BMRN — free
$67.36 -1.17 (-1.71%) At close · Aug 14
Market Cap
$13.04B
Shares
193.57M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Alexander Hardy $21,927,563
Gregory Friberg $7,174,583
Brian Mueller $6,831,812
Cristin Hubbard $5,713,695
C. Greg Guyer $5,691,680
Fiscal 2024
Executive Total
Alexander Hardy $14,853,605
Henry Fuchs $8,127,856
Gregory Friberg $7,221,559
Cristin Hubbard $6,928,261
Brian Mueller $5,498,568
G. Eric Davis $5,058,665
C. Greg Guyer $5,057,033
Fiscal 2023
Executive Total
Jean-Jacques Bienaimé $21,976,020
Alexander Hardy $17,875,236
Henry Fuchs $9,660,818
C. Greg Guyer $5,701,119
Jeff Ajer $5,070,357
Brian Mueller $4,854,192
G. Eric Davis $4,645,918
Fiscal 2022
Executive Total
Jean-Jacques Bienaimé $18,351,880
Henry Fuchs $8,704,454
Jeff Ajer $5,457,338
G. Eric Davis $5,189,142
C. Greg Guyer $5,109,550
Brian Mueller $5,107,284
Fiscal 2021
Executive Total
Jean-Jacques Bienaimé $18,262,538
Henry Fuchs $6,929,366
C. Greg Guyer $5,427,248
Jeff Ajer $4,985,408
Brian Mueller $4,699,165
Fiscal 2020
Executive Total
Jean-Jacques Bienaimé $18,146,399
Henry Fuchs $7,456,575
C. Greg Guyer $6,343,499
Brian Mueller $5,840,531
Robert Baffi $4,688,701
Jeff Ajer $4,536,436
Fiscal 2019
Executive Total
Jean-Jacques Bienaimé $18,405,856
Henry Fuchs $7,017,499
Robert Baffi $6,503,503
Jeff Ajer $6,344,322
Daniel Spiegelman $5,239,902
Brian Mueller $1,676,536
C. Greg Guyer
Fiscal 2018
Executive Total
Jean-Jacques Bienaimé $15,627,893
Henry Fuchs $5,777,729
Jeff Ajer $4,545,383
Daniel Spiegelman $4,521,703
Robert Baffi $4,427,918
Brian Mueller $1,524,685
C. Greg Guyer
Fiscal 2017
Executive Total
Jean-Jacques Bienaimé $15,916,985
Henry Fuchs $7,045,424
Daniel Spiegelman $4,641,875
Jeff Ajer $4,568,302
Robert Baffi $4,473,228

Executive changes

Person Change Filed
Rashmi Ramchandani Appointed 2025-12-17
Erin Burkhart Resigned 2025-08-11
Ian T. Clark Appointed 2025-08-01
Timothy P. Walbert Appointed 2025-02-24
Dr. Henry J. Fuchs Retired 2024-08-22
Jeffrey Ajer Terminated 2024-01-11
Mark Enyedy Appointed 2023-12-20
Athena Countouriotis Appointed 2023-12-20
Barbara Bodem Appointed 2023-12-20
Alexander Hardy Appointed 2023-11-03
Richard A. Meier Appointed 2023-11-03
Alexander Hardy Appointed 2023-11-03
Jean-Jacques Bienaimé Retired 2023-11-03
Jean-Jacques Bienaimé Retired 2023-11-03
Dennis J. Slamon, M.D., Ph.D. Appointed 2023-05-30
David E.I. Pyott, M.D. (Hon.) Appointed 2023-05-30
Maykin Ho, Ph.D. Appointed 2023-05-30
V. Bryan Lawlis, Ph.D. Appointed 2023-05-30
Richard A. Meier Appointed 2023-05-30
Robert J. Hombach Appointed 2023-05-30
Elaine J. Heron, Ph.D. Appointed 2023-05-30
Jean-Jacques Bienaimé Appointed 2023-05-30
Willard Dere, M.D. Appointed 2023-05-30
Elizabeth McKee Anderson Appointed 2023-05-30
Mark J. Alles Appointed 2023-05-30
Key facts CIK 1048477 CUSIP 09061G101 13F (30d) 543 filings 511 filers Visit website Investor relations